Jing Wu

20120306494, Dec 6, 2012

May 31, 2011

13/149760

Xing Yang - Hartsdale NY, US
Teck Beng Desmond Yeo - Clifton Park NY, US
Xu Chu - Shanghai, CN
Thomas Kwok-Fah Foo - Clifton Park NY, US
Jing Wu - Boston MA, US

GENERAL ELECTRIC COMPANY - Schenectady NY

G01R 33/44

324318

A system including a plurality of coil elements is provided. Each coil element is arranged with a first switch and a second switch. In a first mode, the first switch and the second switch are turned off to split each coil element into a first coil portion and a second coil portion, to transmit first radio frequency signals. In a second mode, the first switch and second switch are turned on to transform each coil element into a loop coil to simultaneously transmit or receive multiple second radio frequency signals.

52120821, May 18, 1993

Mar 13, 1991

7/669446

Menek Goldstein - New York NY
Jing Wu - New York NY
David Filer - New York NY
Arnold J. Friedhoff - New York NY

New York University - New York NY

C12N 904
C12N 1500

435190

Modification of the DNA encoding the enzyme tyrosine hydroxylase (TH) resulting in amino acid substitution in one of the first fifty five N-terminal residues, in particular replacing Ser-40 with Tyr or Leu, produced TH variants having substantially increased enzymatic activity upon transfection of suitable host cells. Cells transfected with the variant TH having enhanced enzymatic activity are useful for treating neurological or psychiatric disorders associated with deficient TH or dopamine, in particular Parkinson's disease, by grafting such cells into the brain.

53004361, Apr 5, 1994

Jan 26, 1993

8/009075

Menek Goldstein - New York NY
Jing Wu - New York NY
David Filer - New York NY
Arnold J. Friedhoff - New York NY

New York University - New York NY

C12N 1500
C12N 904

4352523

Modification of the DNA encoding the enzyme tyrosine hydroxylase (TH) resulting in amino acid substitution in one of the first fifty five N-terminal residues, in particular replacing Ser-40 with Tyr or Leu, produced TH variants having substantially increased enzymatic activity upon transfection of suitable host cells. Cells transfected with the variant TH having enhanced enzymatic activity are useful for treating neurological or psychiatric disorders associated with deficient TH or dopamine, in particular Parkinson's disease, by grafting such cells into the brain.